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Abstract
Using a matched case control design conducted at MRC Gambia in 2015, we measured vitamin D levels in pairs of asymp-
tomatic children with discordant tuberculin skin test status despite the same sleeping proximity to the same adult TB index 
case. Median ages of groups (infected; 10.0 years, uninfected 8.8 years) were not significantly different (p = 0.13). Mean 
vitamin D levels were 2.05 ng/mL (95% CI − 0.288 to 4.38) higher in 24 highly TB-exposed uninfected children compared 
with 24 matched highly TB-exposed infected children (p = 0.08). The findings warrant further investigation in larger studies 
to understand the implications and significance.
 Conclusion: Vitamin D levels were higher in TB-uninfected children compared with TB-infected despite equal high 
exposure to a TB case.
What is Known:
• Paediatrics TB represents one of the leading causes of child death globally.
• Current literature shows an inconsistent relationship between vitamin D deficiency and increased risk of TB disease however a large Phase 3 
trial of vitamin D supplementation in (largely vitamin D deficient) Mongolian children did not find any association with TB infection rates.
What is New:
• This study adds to the literature in a vitamin D sufficient paediatric population whereby children with equal exposure to a household TB case 
with no evidence of TB infection have higher levels of vitamin D compared with matched children with TB infection.
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Abbreviations
IGRA  Interferon-gamma release assay
M.tb  Mycobacteria tuberculosis
TB  Tuberculosis
TST  Tuberculin skin test
VDR  Vitamin D receptor
Introduction
Vitamin D deficiency has been associated with increased 
risk of tuberculosis (TB) disease 1, and infection 2; however, 
the definition of vitamin D deficiency is inconsistent. Host 
vitamin D receptor (VDR) genetic variants are also associ-
ated with risk of TB disease 3. Although vitamin D supple-
mentation has recently been shown not to prevent latent TB 
infection in Mongolian children 4, vitamin D levels are influ-
enced by genetics, cultural factors, diet, and latitude, making 
it unclear how these findings may relate to tropical African 
settings 5. Vitamin D is an immunomodulator with IFN-γ-
dependent and IFN-γ and TNF-α-independent host mecha-
nisms to control mycobacteria 6. Vitamin D-dependent anti-
microbial peptides are hypothesised to down-regulate host 
pro-inflammatory responses responsible for lung pathology 
seen in TB disease 7. A negative tuberculin skin test (TST) 
or interferon-gamma release assay (IGRA) in an individ-
ual with a high risk of Mycobacteria tuberculosis (M.tb) 
exposure is likely evidence of elimination of the infection 
via innate immune responses or acquired immune response 
without T cell priming or memory 8. We hypothesised that 
vitamin D levels would be higher in highly TB-exposed 
uninfected Gambian children compared with matched highly 
TB-exposed infected children. We therefore measured vita-
min D levels in stored samples from a 2015 study of pairs of 
children with discordant latent tuberculosis infection status 
despite matched exposure to the same household adult tuber-
culosis index case 9.
Materials and methods
Participant characteristics
As previously reported 9, pairs of asymptomatic children 
(5–15 years old) with discordant TST status despite equal 
sleeping proximity in the same building to the same adult 
index case with smear-positive pulmonary tuberculosis were 
recruited in the MRC Unit, The Gambia in 2015 (highly 
TB-exposed uninfected and highly TB-exposed infected 
children). Briefly, newly identified adult (> 15 years) smear 
positive TB cases were approached for consent. Children 
(< 15 years) within a cluster of the index case were con-
sented for screening of TB symptoms and TST evaluation. 
Highly TB-exposed infected children were those with 
TST ≥ 10 mm. These children had an in-house IGRA test 
and were referred for further investigation for symptoms. 
All participants were screened for TB symptoms at three-
monthly intervals for 1 year. Highly TB-exposed uninfected 
children were defined as TST negative (≤ 5 mm) at study 
initiation, and at a second TST 3 months after enrolment, 
despite exposure. All highly TB-exposed infected children 
were HIV negative, as were the adult TB index cases. Neo-
natal BCG vaccination in The Gambia is estimated at 98% 
10; however, BCG vaccination status for participants was 
not collected.
Inclusion and exclusion criteria
Smear positive index cases with more than two child con-
tacts (between the ages of 5 and 15 years) were eligible 
for inclusion. After a valid TST had been placed, read, 
and recorded, only instances where at least one child had 
a TST ≥ 10 mm and at least one child had a TST ≤ 5 mm 
and parental or guardian consent had been given were 
included.
Children < 5 years were excluded from this study as they 
were prescribed isoniazid preventative treatment as recom-
mended by the WHO. Children were excluded if they had 
previously received treatment for TB infection or disease, 
or if they showed TB symptoms, or had an abnormal chest 
radiograph.
Sample procedures
Venous blood was collected and serum separated from lithium 
heparin vacutainer tubes (BD, Oxford, UK). Samples were stored 
at – 80 °C and shipped on dry ice prior to thawing for analysis.
Vitamin D quantitation
Vitamin D (25(OH)D) in serum was measured using a 
commercial FDA-approved, validated enzyme immunoas-
say according to manufacturer instructions (Immunodiag-
nostic Systems, UK). Vitamin D levels in ng/mL were read 
from a standard curve. Vitamin D deficiency here is defined 
as < 10 ng/mL and insufficiency as < 20 ng/mL 11.
Statistical analyses
Shapiro–Wilk test was used to assess data distribution. 
Paired students’ t test was conducted on the difference 
in ng/mL 25(OH)D within matched pairs. Wilcoxon’s 
matched pairs signed rank test was used for age compari-
sons. McNemars Χ2 test was used for sex comparisons. 
Analyses were conducted using GraphPad Prism.
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Ethical approval
The study was approved by The Gambia Government/MRC 
Joint Ethics Committee (SCC1405 and SCC1273) and the 
Imperial College Healthcare Tissue Bank (R13071).
Results
Of the 58 children (29 pairs) recruited to the study, five pairs 
did not have sufficient stored serum volume for vitamin D 
measurement for both children in a pair. The remaining 24 
pairs (48 children) were included in analyses (Table 1). 
Median ages did not significantly differ between infected 
(10.0 years) and uninfected (8.8 years; p = 0.13). There 
was no significant difference in the proportion of males to 
females in either group (children = 0.77). Four highly TB-
exposed infected children had negative or indeterminate 
IGRA. No participants developed active TB disease during 
12 months of follow-up.
Mean levels of vitamin D for 24 highly TB-exposed 
infected children was 18.72 ng/mL; range 10.9–28.6 ng/
mL (46.8 nmol/L; range 27–71.5 nmol/L) and 24 highly 
TB-exposed uninfected children was 20.76 ng/mL; range 
12.6–29.7 ng/mL (51.9 nmol/L; range 31.5–74.3 nmol/L), 
difference 2.05 ng/mL, 95% CI -0.288 to 4.38, p = 0.083; 
Fig. 1A). While no children included in this study were vita-
min D deficient using the threshold of 10 ng/mL, 37.5% 
of highly TB-exposed uninfected children and 62.5% of 
highly TB-exposed infected children would be classed as 
insufficient, being below 20 ng/mL. The difference in pro-
portions of vitamin D insufficient children is not signifi-
cantly different between the two groups (p = 0.08, Table 1.)
aWilcoxon’s matched pairs signed rank test, bMcNemars 
Χ2 test, cpaired Student’s t test.
As was conducted previously 9, a subgroup analysis was 
performed excluding the four pairs where the highly TB-
exposed infected children had discordant IGRA/TST results. 
This subgroup analysis included 40 children (median ages 
9.8 years and 9.1 years for infected and uninfected respec-
tively; p = 0.44). Highly TB-exposed infected children had a 
mean vitamin D level of 18.08 ng/mL; range 10.9–28.6 ng/
mL) (45.2 nmol/L; range 27.3–71.5 nmol/L), whereas the 
matched highly TB-exposed uninfected children had a mean 
level of 20.5 ng/mL; range 12.6–29.7 ng/mL (51.3 nmol/L; 
range 31.5- 74.3 nmol/L), difference 2.46 ng/mL, 95% CI 
-0.17 to 5.09, p = 0.065, Fig. 1B). All children (infected and 
uninfected) included in this study were above the thresh-
old of 10 ng/mL (25 nmol/mL) for vitamin D deficiency 
(Fig. 1B).
Discussion
Understanding paediatric protective immunity to acquisi-
tion of TB infection is vital in order to guide targeting of 
preventative and adjunctive therapy, vaccine design, and 
evaluation. Here, we compared vitamin D levels in latently 
infected children in a TB endemic country in children with 
a persistently negative TST despite matched household M.tb 
exposure. We identified a trend towards lower vitamin D 
Table 1  Summary of participant 
characteristics






n 24 24 -
Sleeping proximity to index case
Same room 1 1 -
Same house 23 23 -
Median age years (IQR, range) 8 (6.5–12, 5–14) 10 (8–12, 6–14) 0.13a
Males number (%) 12 (50.0%) 13 (54.2%) 0.77b
HIV infection in child (n = 24) - 0 -
Median initial TST result in mm (IQR) - 18 (15–20) 0.00a
Median repeat TST result in mm (IQR) 0 (0) - -
Initial IGRA results (%)
Positive - 20 (83.3%) -
Negative - 3 (12.5%) -
Indeterminate - 1 (4.2%) -
Mean vitamin D levels in ng/mL (range) 20.76 (12.6–29.7) 18.72 (10.9–28.6) 0.083c
Number (%) with vitamin D deficiency (< 10 ng/mL) 0 0 -
Number (%) with vitamin D insufficiency (< 20 ng/mL) 9 (37.5%) 15 (62.5%) 0.08b
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levels in children with TB infection than those without evi-
dence of infection; however, this did not reach significance. 
The trend was consistent in the subgroup analysis restricted 
to pairs of children where the highly TB-exposed infected 
children had consistent IGRA/TST results at baseline.
A 2020 household contact study in UK children found 
a stepwise decline in vitamin D levels from non-infected 
children to those with TB infection and then children with 
TB disease, with a significant difference between those with 
TB infection and TB disease 12. In a large study of 9810 
Mongolian school children, Ganmaa et al. report an adjusted 
risk ratio of 1.23 [95% CI, 1.08–1.40], p = 0.002 for vitamin 
D deficiency, defined as < 10 ng/mL, and TB infection as 
determined by the QuantiFERON-TB (QFT) Gold assay 2. 
A subsequent phase 3 randomised controlled study in over 
8,800 Mongolian children found that vitamin D oral sup-
plementation over 3 years was not associated with any dif-
ference in QFT positivity, despite a mean increase of over 
20 ng/mL vitamin D in the supplemented group 4.
A meta-analysis of 3,544 (mainly adult) participants 
from 13 countries included in prospective trials investigat-
ing vitamin D and TB risk found a median vitamin D level 
of 26 ng/mL (65.0 nmol/L; IQR 19.5–33.4 ng/mL) and a 
dose-dependent relationship between deficiency of vitamin 
D (< 10 ng/mL) and increased risk of incident TB, a find-
ing which was significantly exacerbated by HIV 1. Another 
meta-analysis restricted to children < 18 years found that 
vitamin D deficiency was associated with TB with a pooled 
OR of 1.78 (95% CI 1.30–2.44, p < 0.05); however, the 
definition of vitamin D deficiency varied between < 30 ng/
mL, < 20 ng/mL, and < 10 ng/mL in the studies included 13. 
The applicability of these findings to the Gambian popu-
lation being studied here is not clear. While no Gambian 
children studied here would be classed as deficient using the 
10 ng/mL (25 nmol/L) threshold for vitamin D deficiency, 
between 37.5% (highly TB-exposed uninfected) and 62.5% 
(highly TB-exposed infected) would be classed as insuffi-
cient by the thresholds used here. The Mongolian phase 3 
study found that 31.8% of children had vitamin D levels 
below 10 ng/mL 4, and between 24% (of uninfected chil-
dren) and 63% (of children with TB disease) included in the 
UK study were deemed vitamin D deficient using the same 
threshold 12.
While the trend between elevated vitamin D and absence 
of TB infection despite high TB-exposure reported here is 
consistent with results from existing literature 1, 12, a study 
in Gambian adults reporting higher serum vitamin D levels in 
adults with TB disease compared to household contacts 5 points 
towards variation in associations even within the same country.
Strengths of this study include the careful exposure-
matched study design, comparing experimental data on 
samples from school-age children with TB infection to those 
who remain persistently uninfected despite defined house-
hold contact with an adult with smear-positive pulmonary 
tuberculosis. The original study was not powered to detect 
differences in vitamin D levels. Therefore, the small sample 
size of pairs of children from whom sufficient sample was 
available for this exploratory analysis is a limitation. IGRA 
status was available at baseline for the highly TB-exposed 
infected children but was not available for the highly TB-
exposed uninfected children. Potentially confounding factors 
that may affect vitamin D levels (such as diet) are likely to be 
equally distributed within pairs living in the same household 
compound; therefore, the magnitude of vitamin D differ-
ences may be small.
Our data from this largely vitamin D-sufficient group of 
children with household tuberculosis exposure in a tropi-
cal African climate contribute to the body of evidence that 
Fig. 1  A&B Vitamin D levels 
among 24 matched pairs (A) 
and 20 matched (pairs subgroup 
analysis restricted to 20 pairs of 
children where the highly TB-
exposed infected children had 
consistent IGRA/TST results 
at baseline, B) of highly TB-
exposed uninfected and infected 
children. Red dotted line 
represents vitamin D deficiency 
threshold of 10 ng/mL; grey 
dotted line represents vitamin 
D insufficiency threshold of 
20 ng/mL
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higher vitamin D levels may be linked to lower risk of 
acquisition of TB infection. Larger studies utilising similar 
epidemiological designs in high TB-prevalence countries 
with distinct climates are required to further elucidate the 
connection between vitamin D levels and immunity against 
tuberculosis infection.
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